AZTA - Azenta Inc
IEX Last Trade
49.49
0.180 0.364%
Share volume: 485,423
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$49.31
0.18
0.37%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-08-09 | 2022-11-25 | 2023-02-09 | 2023-05-10 | 2023-08-09 | 2023-11-21 | 2024-02-08 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 3.723 B | 3.716 B | 3.292 B | 3.250 B | 3.069 B | 2.886 B | 2.824 B | 2.563 B | |
| Current Assets | 2.575 B | 2.459 B | 1.620 B | 1.586 B | 1.511 B | 1.419 B | 1.383 B | 1.190 B | |
| Inventories | 81.213 M | 85.544 M | 145.939 M | 150.727 M | 142.102 M | 128.198 M | 127.184 M | 122.351 M | |
| Other Current Assets | 160.557 M | 257.410 M | 133.854 M | 82.010 M | 79.568 M | 111.790 M | 110.764 M | 88.247 M | |
| Short Term Investments | 160.557 M | 257.410 M | 133.854 M | 82.010 M | 79.568 M | 111.790 M | 110.764 M | 88.247 M | |
| Total Receivables | 150.274 M | 163.758 M | 201.920 M | 167.960 M | 163.019 M | 156.535 M | 155.926 M | 154.668 M | |
| Current Cash | 2.183 B | 1.570 B | 1.131 B | 1.181 B | 1.124 B | 1.018 B | 984.135 M | 821.711 M | |
| Total Non-current Assets | 1.147 B | 1.257 B | 1.672 B | 1.664 B | 1.559 B | 1.467 B | 1.442 B | 1.373 B | |
| Property Plant Equipment | 154.596 M | 154.470 M | 217.271 M | 215.301 M | 210.940 M | 205.744 M | 210.628 M | 200.905 M | |
| Other Assets | 53.296 M | 57.093 M | 61.929 M | 67.692 M | 71.940 M | 70.471 M | 77.187 M | 10.155 M | |
| Intangible Assets | 160.691 M | 178.401 M | 327.106 M | 323.927 M | 312.055 M | 294.301 M | 290.229 M | 267.626 M | |
| Goodwill | 464.885 M | 513.623 M | 761.153 M | 790.494 M | 793.623 M | 784.339 M | 800.166 M | 681.140 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.723 B | 3.716 B | 3.292 B | 3.250 B | 3.069 B | 2.886 B | 2.824 B | 2.563 B | |
| Total liabilities | 294.931 M | 352.736 M | 421.027 M | 354.587 M | 345.916 M | 351.220 M | 380.650 M | 340.626 M | |
| Total current liabilities | 194.927 M | 230.546 M | 249.026 M | 212.644 M | 203.627 M | 210.928 M | 235.620 M | 202.999 M | |
| Accounts Payable | 34.576 M | 38.654 M | 55.259 M | 45.306 M | 37.990 M | 35.796 M | 40.237 M | 37.319 M | |
| Other liabilities | 8.999 M | 8.408 M | 33.621 M | 14.702 M | 14.790 M | 12.555 M | 12.686 M | 11.986 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.999 M | 8.408 M | 33.621 M | 14.702 M | 14.790 M | 12.555 M | 12.686 M | 11.986 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.428 B | 3.363 B | 2.871 B | 2.895 B | 2.724 B | 2.535 B | 2.444 B | 2.223 B | |
| Common stock | 74.989 M | 75.011 M | 72.543 M | 69.111 M | 63.432 M | 59.926 M | 56.709 M | 55.440 M | |
| Retained earnings | 1.676 B | 1.655 B | 1.644 B | 1.639 B | 1.638 B | 1.641 B | 1.625 B | 1.488 B |